MedPath

The effect of electroacupuncture in the prevention of chemotherapy induced peripheral neuropathy in colon cancer patient - pilot study

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0001349
Lead Sponsor
Daegu Catholic Univercity Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

1. proven colorectal cancer patient
2. age between 18 - 75 yrs
3. Patients who receive FOLFOX chemotherapy including Oxaliplatin
4 less than Eastern Cooperative Oncology Group (ECOG) performance status 2
5. patient who is possible to follow up

Exclusion Criteria

1. current metastatic colorectal cancer
2. patients who had the experience of being treated due to peripheral neuropathy previously
3. previously being treated with neurotoxic chemotherapeutic agents
4. patients who need operation due to neurologic symptoms
5. prenant, breastfeeding woman
6. patients who have psychological diseases or problems
7. patients who do not agree with the trial
8. Diabetes, chronic renal failure, alcoholics and other addictive patients
9. patients who have anticonvulsants, antidepressant and major painkiller periodically
10. moderate to severe hepatotoxicity or renal toxicity
11. allergic or hyper-reactive response to acupunture

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CTCAE(Common Terminology Criteria for Adverse Effect) grading system, OSNS(Oxaliplatin-Specific Neurotoxicity Scale),(VAS, EORTC(QLQ-CIPN20) Questionaire)
Secondary Outcome Measures
NameTimeMethod
CV(Nerve Conduction Velocity), CMAP(compound motor action potential), CSAP(compound sensory action potential)
© Copyright 2025. All Rights Reserved by MedPath